Annovis Bio

$10.09
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.02 (-0.15%) Today
+$0.07 (+0.70%) As of 11:01 PM UTC after-hours

Why Robinhood?

You can buy or sell Annovis Bio and other stocks, options, and ETFs commission-free!

About ANVS

Annovis Bio, Inc. develops drugs for Alzheimer's and Parkinson's diseases and other neurodegenerative disorders. It offers posiphen compound for mild cognitive impairment and early stage Alzheimer's disease and bisnorcymserine compound that inhibits amyloid formation and prevents the progression of the Alzheimer's disease. The company was founded by Maria Luisa Maccecchini in May 2008 and is headquartered in Berwyn, PA. The listed name for ANVS is Annovis Bio, Inc.

CEO
Maria-Luisa Maccecchini
Employees
2
Headquarters
Berwyn, Pennsylvania
Founded
2008
Market Cap
68.78M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
94.00K
High Today
$10.02
Low Today
$9.60
Open Price
$10.00
Volume
35.46K
52 Week High
$10.61
52 Week Low
$2.42

Collections

ANVS Earnings

-$0.34
-$0.23
-$0.11
$0.00
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Feb 20, Pre-Market

You May Also Like

LL
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure